MENU
+Compare
MDWD
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$18.02
Change
+$0.05 (+0.28%)
Capitalization
194.86M

MDWD MediWound Ltd Forecast, Technical & Fundamental Analysis

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications... Show more

MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MDWD with price predictions
Apr 23, 2025

Momentum Indicator for MDWD turns positive, indicating new upward trend

MDWD saw its Momentum Indicator move above the 0 level on April 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MDWD just turned positive on April 11, 2025. Looking at past instances where MDWD's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

MDWD moved above its 50-day moving average on April 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDWD advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for MDWD moved below the 200-day moving average on April 07, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDWD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MDWD broke above its upper Bollinger Band on April 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MDWD entered a downward trend on April 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDWD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.254) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (8.881) is also within normal values, averaging (252.992).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MDWD is expected to report earnings to rise 79.17% to -64 cents per share on May 28

MediWound Ltd MDWD Stock Earnings Reports
Q1'25
Est.
$-0.64
Q4'24
Beat
by $0.20
Q3'24
Missed
by $0.53
Q2'24
Missed
by $0.24
Q1'24
Missed
by $0.64
The last earnings report on March 19 showed earnings per share of -36 cents, beating the estimate of -56 cents. With 39.22K shares outstanding, the current market capitalization sits at 194.86M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
42 Hayarkon Street
Phone
+972 779714100
Employees
100
Web
https://www.mediwound.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BVPIX21.220.17
+0.81%
Baywood ValuePlus Institutional
GOGIX28.53N/A
N/A
JHancock International Growth I
IVITX20.33N/A
N/A
VY® Invesco Growth and Income S2
FERIX49.12N/A
N/A
Fidelity Advisor Emerging Asia I
BMSTX12.68N/A
N/A
MFS Blended Research Mid Cap Eq R3

MDWD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
N/A
PHIO - MDWD
35%
Loosely correlated
-18.33%
AKRO - MDWD
33%
Poorly correlated
+2.88%
KANT - MDWD
30%
Poorly correlated
-27.79%
KALA - MDWD
26%
Poorly correlated
+8.43%
MESO - MDWD
26%
Poorly correlated
+2.21%
More